{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:01:28Z","timestamp":1787918488490,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Medical cannabis consumption is rising, but limited evidence informs the safety and efficacy of cannabis use in cancer patients. A national survey of oncology trainees found that most fellows felt insufficiently informed to make clinical recommendations about cannabis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>In this secondary analysis, we aimed to measure how frequently trainees recommend in favor of cannabis and determine factors influencing this clinical practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this cross-sectional survey study for fellows enrolled in oncology training programs across the United States, an online survey assessing trainee practices regarding medical cannabis was sent to 155 oncology fellowship program directors from January - March 2021; who were asked to distribute it to their fellows. The primary outcome was the frequency with which oncology fellows recommended cannabis in the prior year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nationally, 40 programs from 25 states participated, with 189 of 462 trainees across these programs responding (40.9% response rate). 22% (95% CI: 16.3\u201329.0%) of participants reported recommending medical cannabis to &gt;\u20095 patients in the past year. 24% (95% CI: 18.4\u201330.5%) of participants had prior training in medical cannabis. Regarding participant characteristics, only prior training in medical cannabis was significantly associated with recommending cannabis to &gt;\u20095 patients (RR: 2.4; 95% CI: 1.4\u20134.2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>With increasing cannabis use among patients with cancer and given that a substantial number of oncology fellows recommend its use, it is crucial that fellowship training incorporate evidence-based curricula regarding medical cannabis use to guide informed decision-making between patients and their fellow providers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42238-025-00293-9","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:42:43Z","timestamp":1752504163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns and factors among oncology fellows recommending medical cannabis to adults with cancer"],"prefix":"10.1186","volume":"7","author":[{"given":"Kian","family":"Tehranchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushad","family":"Patell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorva","family":"Bindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Freed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara A.","family":"Schonberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Rangachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"2","key":"293_CR27","first-page":"161","volume":"78","author":"J Bethlehem","year":"2010","unstructured":"Bethlehem J. Selection Bias in web surveys. Int Stat Rev \/ Revue Int De Statistique. 2010;78(2):161\u201388.","journal-title":"Int Stat Rev \/ Revue Int De Statistique"},{"key":"293_CR11","doi-asserted-by":"crossref","unstructured":"Braun IM, Bohlke K, Abrams DI, Anderson H, Balneaves LG, Bar-Sela G et al. Cannabis and cannabinoids in adults with cancer: ASCO guideline. J Clin Oncol. 2024a:Jco2302596.","DOI":"10.1200\/JCO.23.02596"},{"issue":"6","key":"293_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1200\/OP.23.00775","volume":"20","author":"IM Braun","year":"2024","unstructured":"Braun IM, Bohlke K, Roeland EJ. Cannabis and cannabinoids in adults with cancer: ASCO guideline Q&A. JCO Oncol Pract. 2024b;20(6):767\u201370.","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"293_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12875-019-1059-8","volume":"20","author":"J Corroon","year":"2019","unstructured":"Corroon J, Sexton M, Bradley R. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Fam Pract. 2019;20(1):174.","journal-title":"BMC Fam Pract"},{"issue":"8","key":"293_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.7326\/M24-0638","volume":"177","author":"R Crowley","year":"2024","unstructured":"Crowley R, Cline K, Hilden D, Beachy M. Regulatory framework for cannabis: A position paper from the American college of physicians. Ann Intern Med. 2024;177(8):1104\u20135.","journal-title":"Ann Intern Med"},{"issue":"66","key":"293_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/jncimonographs\/lgae029","volume":"2024","author":"GL Ellison","year":"2024","unstructured":"Ellison GL, Helzlsouer KJ, Rosenfield SM, Kim Y, Ashare RL, Blaes AH, et al. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer centers. J Natl Cancer Inst Monogr. 2024;2024(66):202\u201317.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"293_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drugalcdep.2017.08.010","volume":"180","author":"AB Evanoff","year":"2017","unstructured":"Evanoff AB, Quan T, Dufault C, Awad M, Bierut LJ. Physicians-in-training are not prepared to prescribe medical marijuana. Drug Alcohol Depend. 2017;180:151\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"293_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"key":"293_CR14","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"8","key":"293_CR20","first-page":"e28336","volume":"14","author":"RJ Jacobs","year":"2022","unstructured":"Jacobs RJ, Colon J, Kane MN. Medical students\u2019 attitudes, knowledge, and beliefs about medical cannabis: A qualitative descriptive study. Cureus. 2022;14(8):e28336.","journal-title":"Cureus"},{"issue":"2","key":"293_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167\u201379.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"293_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","volume":"10","author":"ME Lynch","year":"2015","unstructured":"Lynch ME, Ware MA. Cannabinoids for the treatment of chronic Non-Cancer pain: an updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol. 2015;10(2):293\u2013301.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"293_CR3","first-page":"429","volume":"31","author":"EA McClure","year":"2023","unstructured":"McClure EA, Walters KJ, Tomko RL, Dahne J, Hill EG, McRae-Clark AL. Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access. Support Care Cancer. 2023;31(7):429.","journal-title":"Support Care Cancer"},{"key":"293_CR23","doi-asserted-by":"publisher","first-page":"1282831","DOI":"10.3389\/fphar.2024.1282831","volume":"15","author":"R Nachnani","year":"2024","unstructured":"Nachnani R, Knehans A, Neighbors JD, Kocis PT, Lee T, Tegeler K, et al. Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis. Front Pharmacol. 2024;15:1282831.","journal-title":"Front Pharmacol"},{"issue":"11","key":"293_CR13","doi-asserted-by":"publisher","first-page":"e1762","DOI":"10.1200\/OP.21.00714","volume":"18","author":"R Patell","year":"2022","unstructured":"Patell R, Bindal P, Dodge L, Elavalakanar P, Freed JA, Rangachari D, et al. Oncology fellows\u2019 clinical discussions, perceived knowledge, and formal training regarding medical Cannabis use: A National survey study. JCO Oncol Pract. 2022;18(11):e1762\u201376.","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"293_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.6004\/jnccn.2024.7084","volume":"23","author":"R Patell","year":"2025","unstructured":"Patell R, Bindal P, Freed J, Dodge LE, Nagaraj G, LaCasce AS, et al. A multicenter feasibility study of a novel curriculum for oncology trainees regarding medical Cannabis. J Natl Compr Canc Netw. 2025;23(3):82\u20139.","journal-title":"J Natl Compr Canc Netw"},{"issue":"22","key":"293_CR1","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","volume":"123","author":"SA Pergam","year":"2017","unstructured":"Pergam SA, Woodfield MC, Lee CM, Cheng GS, Baker KK, Marquis SR, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123(22):4488\u201397.","journal-title":"Cancer"},{"issue":"5","key":"293_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, et al. Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain. 2012;13(5):438\u201349.","journal-title":"J Pain"},{"issue":"6","key":"293_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cac2.12160","volume":"41","author":"TS Sannes","year":"2021","unstructured":"Sannes TS, Nayak MM, Tung S, Chai PR, Yusufov M, Bolcic-Jankovic D, et al. United States oncologists\u2019 clinical preferences regarding modes of medicinal cannabis use. Cancer Commun (Lond). 2021;41(6):528\u201331.","journal-title":"Cancer Commun (Lond)"},{"key":"293_CR6","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.ctim.2020.102328","volume":"49","author":"M St Pierre","year":"2020","unstructured":"St Pierre M, Matthews L, Walsh Z. Cannabis education needs assessment among Canadian physicians-in-training. Complement Ther Med. 2020;49:102328.","journal-title":"Complement Ther Med"},{"issue":"1","key":"293_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11912-019-0757-7","volume":"21","author":"G Steele","year":"2019","unstructured":"Steele G, Arneson T, Zylla D. A comprehensive review of Cannabis in patients with cancer: availability in the USA, general efficacy, and safety. Curr Oncol Rep. 2019;21(1):10.","journal-title":"Curr Oncol Rep"},{"issue":"13","key":"293_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1503\/cmaj.071178","volume":"178","author":"T Wang","year":"2008","unstructured":"Wang T, Collet JP, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008;178(13):1669\u201378.","journal-title":"CMAJ"},{"issue":"2","key":"293_CR12","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3747\/co.23.3185","volume":"23","author":"MA Ware","year":"2016","unstructured":"Ware MA. Cannabis and cancer: toward a new Understanding. Curr Oncol. 2016;23(2):S5\u20136.","journal-title":"Curr Oncol"},{"issue":"1","key":"293_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-021-00100-1","volume":"3","author":"JM Weisman","year":"2021","unstructured":"Weisman JM, Rodr\u00edguez M. A systematic review of medical students\u2019 and professionals\u2019 attitudes and knowledge regarding medical cannabis. J Cannabis Res. 2021;3(1):47.","journal-title":"J Cannabis Res"},{"issue":"1","key":"293_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cncr.33906","volume":"128","author":"MC Weiss","year":"2022","unstructured":"Weiss MC, Hibbs JE, Buckley ME, Danese SR, Leitenberger A, Bollmann-Jenkins M, et al. A Coala-T-Cannabis survey study of breast cancer patients\u2019 use of cannabis before, during, and after treatment. Cancer. 2022;128(1):160\u20138.","journal-title":"Cancer"},{"key":"293_CR24","doi-asserted-by":"crossref","unstructured":"Woerdenbag HJ, Olinga P, Kok EA, Brugman DAP, van Ark UF, Ramcharan AS et al. Potential, limitations and risks of Cannabis-Derived products in Cancer treatment. Cancers (Basel). 2023;15(7).","DOI":"10.3390\/cancers15072119"},{"issue":"11","key":"293_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1200\/OP.22.00080","volume":"18","author":"B Worster","year":"2022","unstructured":"Worster B, Hajjar ER, Handley N. Cannabis use in patients with cancer: A clinical review. JCO Oncol Pract. 2022;18(11):743\u20139.","journal-title":"JCO Oncol Pract"},{"key":"293_CR28","doi-asserted-by":"publisher","first-page":"102675","DOI":"10.1016\/j.ctim.2021.102675","volume":"58","author":"Y Zolotov","year":"2021","unstructured":"Zolotov Y, Metri S, Calabria E, Kogan M. Medical cannabis education among healthcare trainees: A scoping review. Complement Ther Med. 2021;58:102675.","journal-title":"Complement Ther Med"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00293-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00293-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00293-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:11:26Z","timestamp":1757236286000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00293-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00293-9","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Answering the survey was voluntary and done anonymously. All the participants consented to participate in this study. The Institutional Review Board at the Beth Israel Deaconess Medical Center approved the study as exempt from human subject research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}